Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With Histologic Risk Factors: Are We Over-Treating?

No evidence was found to support the application of PORT given the indication of histologic risk factors alone. The prescription of PORT for PNI, lymphovascular invasion, and unfavorable grading among otherwise low-risk OSCC needs to be approached with caution to avoid the unnecessary harm of radiation exposure.